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Background: Patient preference is one of the main components of clinical decision making, therefore leading to
the development of patient decision aids. The goal of this study was to describe physicians’ and patients’
viewpoints on the barriers and limitations of using patient decision aids in Iran, their proposed solutions, and, the
benefits of using these tools.
Methods: This qualitative study was conducted in 2011 in Iran by holding in-depth interviews with 14 physicians
and 8 arthritis patient. Interviewees were selected through purposeful and maximum variation sampling. As an
example, a patient decision aid on the treatment of knee arthritis was developed upon literature reviews and
gathering expert opinion, and was presented at the time of interview. Thematic analysis was conducted to analyze
the data by using the OpenCode software.
Results: The results were summarized into three categories and ten codes. The extracted categories were the
perceived benefits of using the tools, as well as the patient-related and physician-related barriers in using decision
aids. The following barriers in using patient decision aids were identified in this study: lack of patients and
physicians’ trainings in shared decision making, lack of specialist per capita, low treatment tariffs and lack of an
exact evaluation system for patient participation in decision making.
Conclusions: No doubt these barriers demand the health authorities’ special attention. Hence, despite patients and
physicians’ inclination toward using patient decision aids, these problems have hindered the practical usage of
these tools in Iran - as a developing country.
Keywords: Patient decision aid tool, Qualitative study, IranBackground
There is strong evidence for the potential outcomes of a
treatment and its effectiveness or harm in only 17% of
cases. For others, which include most decisions, there is
no definite evidence about the balance between their
benefits and harms. In these cases, choosing the right
treatment according to the patients’ conditions is diffi-
cult. Therefore, they need to be involved in the decision
making process. Based on scientific evidence, taking* Correspondence: nejatsan@tums.ac.ir
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reproduction in any medium, provided the orpatients’ opinions into consideration can ease decision
making in such conditions [1,2].
Involving patients in medical decisions requires their
awareness of all existing treatments, their outcomes and
the extent to which treatments would correspond to
their own conditions. Different studies have shown that
using patient decision aids (PDA) can facilitate this
process. Patient value is one of the main principles of
evidence-based medicine and clinical decision making.
Therefore, there is increasing focus on designing PDAs.
PDAs have been provided in different forms of media
such as decision boards, video CDs, audio tapes, e-books,
pamphlets, and group presentations. They have made the
existing evidence on treatment benefits and harms easierral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patient select a treatment to his/her own benefit, based on
his/her own values [7].
It is well documented that PDAs increase patients’ in-
volvement in the process of decision making [2,3,5,6,8-14].
In fact, it gives them a more realistic view about diseases
and their probable harms and side effects, and increases
their assurance in decision making [5,6,8,15,16]. Moreover,
this tool offers patients an active and collaborative role,
leading to more effective, appropriate, safe, responsive and
high quality health care [2].
More than 300 decision aids have been registered in
the Cochrane Registry System and Ottawa Hospital web-
site, all of which are from high-income countries, such
as: United States, Canada, United Kingdom, Australia,
Saudi Arabia, Netherlands and Germany, respectively in
order of frequency [17]. The development of this tool
has not yet been the focus of attention in developing
countries. However, in Iran developing guidelines as a part
of evidence-based medicine has begun a long time ago
and is ongoing [18]. Nevertheless, developing the PDA as
a tool for considering patients’ values and shared decision
making has not gained any attention yet.
Evaluating the possibility of implementing this tool in
Iran can result in useful information about the practicability
of developing this tool in clinical settings. The present study
has explained physicians’ and patients’ opinions about using
this decision aid tool in Iran.
Methods
This qualitative study was conducted in 2011 in Tehran,
Iran, by holding in-depth interviews with 14 physicians
and 8 arthritis patients.
The physicians and patients were selected through
purposeful and maximum variation sampling. Sampling
continued up to data saturation. Physicians were selected
from a diverse range of specialties that could use PDAs.
Both male and female patients from different socio-
economical levels were interviewed. They were selected by
visiting private and public rheumatology and orthopedic
clinics. The specialists were asked to give the contact
information of patients who were candidates of elective
surgery. The interviewer then chose 5 females and 3
males from both upper and lower socio-economic statuses.
The latter was estimated by their residential addresses. Each
interviewee was asked to specify the place and time of the
interview. Before beginning each interview, a sample of the
designed tool was presented to the patients. For instance, a
PDA on knee joint replacement surgery in severe arthritis
was selected and translated to Persian by two physicians
fluent in English; ultimately one version was provided
from two copies. Then, 4 rheumatologists and orthope-
dists were interviewed to evaluate the tool’s content
validity. Meanwhile, the specialty-specific English versionswere presented along with the Persian versions to phy-
sicians of various specialties. They were given some
time to go through the English and Persian versions
before the interview began.
The interviewer was guided by a few open questions
to explore the physicians’ opinions on the compatibility
of tools with Iranian culture, the applicability of this tool
in Iran, the advantages and disadvantages of using this tool,
as well as the changes considered necessary for making the
tools compatible in Iran.
During the patient interviews, after the Persian PDA
tool was explained and presented, questions concerning
patients’ rights, general opinions about their advantages
and disadvantages, appropriateness of content and con-
struct of the tool, and recommendations for upgrading
the tool were asked. All interviews were performed by
the first and second authors who were familiar with
qualitative research methods and had experience in
conducting qualitative interviews. A note-taker was also
present during the interviews, which were audio-taped
upon the interviewees’ permission and subsequently
transcribed verbatim.
Data management was done with OpenCode software.
Inductive thematic analysis was conducted to analyze
the data. The codes and categories were extracted from
the text of the transcripts. Each interview’s text was as-
sumed as a whole and the fundamental meanings or its
general context was described in one or a couple of para-
graphs. Primary codes and categories were determined,
then after frequent analysis, repeated categories and codes
were merged. Member check was conducted to ensure the
trustworthiness of the findings with all physicians. It was
also conducted with two patients whom it was felt neces-
sary to confirm the analysis of the findings with. All the
interviews held with physicians were analyzed by a second
person. But only two patient interviews were analyzed by
a second person. However, since the second person had
been present in all the interviews, the final analysis results
of the patient interviews were approved by the second
person as well. Where reliability was concerned, the inter-
rater agreement between the two analyzers was greater
than 90% for all the interviews.
Ethical approval for the study was obtained from
the Ethics Committee of Tehran University of Medical
Sciences (TUMS) (project code: 88-03-74-9467), which
is in line with the Declaration of Helsinki. In the same
context, participants were informed of the goals and
significance of the research and written informed consents
were obtained. They were asked for permission to record
their voices and were reassured that all gathered infor-
mation would only be used for research purposes, and
would not be given to anyone other than research team
members. Finally, a gift was given to each participant
as a token of appreciation.
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The participating physicians’ specialties by number were as
follows: 3 endocrinologists, 2 neurologists, 2 general
surgeons, 2 oncologists, 1 ophthalmologist, 1 gastroenter-
ologist, 1 dermatologist, 1 cardiologist, and 1 urologist
(14 in all). The patient participants included 5 women
and 3 men. Two of the men and 3 women were selected
from public hospitals and were of lower socio-economic
status (LSES). The remaining participants were of upper
socio-economic status (USES).
Three categories and ten codes were extracted from
the interviews (Table 1). Each of the categories and their
codes have been explained and for each the exact phrases
expressed by some participants have been quoted in Italic
font. The type of participant has also been parenthesized
at the end of the quote in abbreviated form; e.g. woman
from upper socio-economic status has been represented
by ‘W-USES’. And specialists have been represented by
the first few letters of each specialty, e.g. ophthalmologist
by ‘Ophth’ and endocrinologist by ‘Endo’.
Recognized benefits of using the PDA
This category included the five following codes: 1)
Enhancing the psychological impact of treatment, 2)
Adherence to principles of medical ethics, 3) Increasing pa-
tient accountability in clinical decision making, 4) Patients’
treatment follow-up, and 5) Cost reduction, which are
explained below:
Enhancing the psychological impact of treatment
According to the participating physicians, patients become
more familiar with different treatments of a disease and
their advantages and disadvantages by using PDAs. They
therefore have a more realistic point of view and become
psychologically ready for the probable side effects of the
treatment. Physicians even believed that this sharing could
have a positive indirect effect on treatment results.
They believed that although all the side effects wouldTable 1 Codes and categories extracted from the interviews
Category Cod





B: Patient- related barriers in using PDAs 1. P
2. P
C: Physician-related barriers in using PDAs 1. La
2. La
3. Lanot necessarily happen to a patient but it is necessary
for them to be aware of them.
“If something happens to patients and they don’t have
any information, it is harder for them to accept it”
(Neuro)
The participating patients thought likewise. They thought
that using this tool would reduce their doubts in decision
making. This would have a positive mental effect on them
and at the same time, increase their knowledge and share
in making a right decision that would lead to a better result
in treatment. According to the patients, presenting this tool
would increase their trust in physicians and could prevent
multiple and unnecessary referrals.
However, some physicians believed that explaining all
the possible side effects of treatment could raise patients’
anxiety and doubts in making decisions, and could even
make the patients quit altogether.
“Sometimes giving information worsens the situation.
Consider this; it would cause patients to complain
more, because they don't see all the aspects. Seeing the
other side of the coin has its own problems.” (Endo)
“Patients face a dilemma and it becomes difficult for
them to decide. This negatively affects their decision
making.” (Endo)
However, most physicians believed these doubts would
not arise in all patients, but mostly in those with dependent
and obsessed personalities.
Adherence to principles of medical ethics
According to the physicians, taking patients’ autonomy
into consideration is one of the main principles of medical
ethics, i.e. patients should have as much autonomy as
possible. By using PDAs, patients’ beliefs and valuese
hancing the psychological impact of treatment
dherence to principles of medical ethics
creasing patients’ accountability in clinical decision making
atients’ treatment follow-up
ost reduction
atients’ level of education and knowledge concerns
atients’ cultural problems
ck of resources
ck of an evaluation system for monitoring patients and physicians’ rights
ck of an appropriate role model among medical instructors
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in their decisions. One of the physicians believed that:
“By using this method patients are given beneficence
which lets them have at least a primary knowledge of
their disease and helps them realize where they stand.”
(Onco)
Valuing patients’ rights was one of the benefits that
patients mentioned in this study.
Increasing patient accountability in clinical decision making
The participating physicians believed that patients have
gotten used to not taking responsibility for decisions and
prefer physicians to be the decision makers. Using this
tool can make it possible for them to take part in decision
making and to take some responsibility for it. In this regard
some physicians said:
“When making a decision it seems you are responsible
for everything; but when you decide together with the
patient both of you will be held accountable and not
you alone ”. (Gen. Surg)
According to the physicians, this tool gives accurate
and evidence-based information to patients, and may
prevent referring to unreliable databases and can prepare
them to take part in decision making. The patients also
confirmed this idea.
“I like to choose. Choosing for one self is much better
than letting the physician decide. When there is no
other way the physician is asked to choose.” (W-LSES)
“Yes, unfortunately physicians neither explain such
things to patients, nor expect such from them.”
(M-USES)
Patients’ treatment follow-up
According to the participating physicians, giving more
knowledge to patients and involving them in decisions
would make them more cooperative and engaged in their
treatment. Henceforth, they would make regular visits to
follow up their treatments.
Cost reduction
Both participant groups believed using PDAs would
increase the frequency of a correct and appropriate
decision, and may cut unnecessary costs which may
arise because of wrong decisions, and eventually decrease
total costs.
“Eventually costs may become effective, because it
prevents making inappropriate decisions.” (Uro)Some of the physicians also believed that the issue of
cost reduction needs special cost-effectiveness studies
and that such a conclusion could not be so easily drawn.
Patient-related barriers in using PDAs
Patients’ level of education and knowledge concerns
In some physicians’ beliefs, differences in patients’ levels
of education are among the main challenges in using
PDAs. This is problematic especially when most of the
patients are not highly educated. Some physicians thought
that irrespective of the patients’ level of education, they
had less information than physicians and this gave them
less scientific power, thus they would face problems in
deciding. But most physicians believed that even people
of poor socioeconomic status have understood this tool,
and essentially using this tool does not depend on the
patients’ level of education.
“Most of our patients and their families aren't much
different from each other when it comes to decision
making.” (Ophth)
Although some physicians suggested categorizing PDAs
according to patients’ education levels, most others
disagreed with this suggestion. They thought PDAs could
be designed in a scientific and simple way that suits any
level of education.
In order to make PDAs more understandable, some
physicians suggested using treatment algorithms but others
thought this might be expensive and make PDAs suitable
only for a specific group of people. As Iranian culture is
more of an auditory culture and the rate of reading is low
among most of the patients, according to some physicians,
using educational movies as complimentary or replacement
tools for handbooks could be really helpful.
“Most of our patients like to simulate conditions for
themselves and to compare themselves and their
conditions with others.” (Ophth)
Some patients suggested presenting existing infor-
mation in educational CD formats as a replacement for
handbooks. They also thought that illiterates could get
help from their friends or relatives on how to read and
understand PDAs.
Patients’ cultural problems
According to some of the participating physicians, patients
are not used to being the decision makers. This habit can
make them resist the use of PDAs.
“Patients say: “whatever ‘your’ opinion is doctor, if you
think that this (treatment) is going to work for me,
then do it”. (Endo)
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with their own rights is another cultural challenge. Recom-
mendations made by the physicians were that patients
should be aware that making a decision and selecting the
appropriate treatment requires them to have necessary and
adequate information about the disease and its treatments.
Therefore, we should increase the patients’ knowledge level
in a way that they demand their rights from physicians.
“Certain trainings are necessary for our patients;
meaning they need to know that today’s medical
methods are not like mathematical equations. Most of
the times patients choose what should be done for them
by considering its benefits and side-effects.” (Onco)
Another problem stated by physicians was patients’ un-
familiarity with the principles of decision making which
makes the process harder for them. One physician said:
“Perhaps people outside Iran are more familiar with
the language of science and uncertainty, so we should
work more on this concept.” (Onco)
Another solution suggested by physicians was to consider
patient’s mental, spiritual and physical conditions at the
time of presenting PDAs, to increase their cooperation.
Therefore, patients should be in a mentally calm situation
and have enough time for a mutual discussion with the
physician. Presenting this tool at the time of patients’
admission would give them adequate time to decide.
According to the physicians, patient opinion has usu-
ally gained less direct attention. Therefore, asking for
the patient’s opinion about decisions can be misunder-
stood as the physician not having enough knowledge
and experience.
“When you involve a patient, her/his impression is
that “if the physician knew what s/he should do s/he
would not have asked me”.” (Endo)
Whereas patients believed that not only does involving
patients in decision-making not cause a misunderstand-
ing of the physicians’ knowledge, but that it would in-
crease their trust and confidence in them too.
Patients believed that people should be acculturated to
the use of this tool before its widespread application. Ac-
culturation can be done through public media such as
television, radio, newspapers, and magazines.
Physician-related barriers in using PDAs
This category includes three codes, 1) Lack of resources
2) Lack of an evaluation system for monitoring patients’
rights in decision makings 3) Lack of an appropriate role
model among medical instructors; as explained below:Lack of resources
According to the participating physicians, lack of
specialists per capita and consequently lack of time
and increasing workloads have lessened physicians’
tendency toward using this tool and involving patients
in decision making.
“If the patient wants more information, it will take
more of the physician’s time and this is not good for
doctors.” (Endo)
Some physicians suggested using expert teams or trained
nurses to confront the problem of time shortage. However,
in Iranian culture, replacing the physician with someone
else in the medical process is not particularly favored.
“Patients want to see their physicians, no matter
how good and reliable I am as the physician’s
assistant. Eventually the patient wants to see the
physician.” (Neuro)
Some physicians mentioned that the success in using
trained experts depends on the type of disease and its
treatment; meaning, experts cannot be used in compli-
cated cases.
Patient opinion about trained nurses was that the nurse
should be verified by the Ministry of Health or one of the
specialists trusted by the patient.
Another problem mentioned by a number of physicians
was the unrealistic tariffs. In some physicians’ opinions,
unrealistic tariffs have caused physicians to sign contracts
with specific pharmaceutical companies to compensate
for low tariffs and consequently, leading patients to use
those specific medications or treatments.
To confront this problem, physicians suggested setting
rational tariffs for those physicians who use PDAs to make
them more motivated in using them. In their opinion, there
should be certain tariffs compensating the physicians’ time
economically, otherwise their motivations for using the tool
would decrease. One physician said:
“The physician who spends enough time on the patient
should not receive the same benefits as the one who
doesn’t.” (Neuro)
Besides, the physicians believed that using this tool would
be eventually practical in some particular centers but that it
would not have much applicability as a norm in clinics and
hospitals in Iran, due to limitation of resources.
Patients participating in the research thought that physi-
cians do not spend much time and effort on patients and
the physician-patient consultation is limited to some short
questions about the signs and history of the disease. Thus,
this tool can compensate for this shortcoming and allow
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with them.
“Unfortunately they don’t even spend 5 minutes with
the patient. I had to refer to several physicians for this
knee problem that I have.” (W-USES)
Physicians and patients disagreed on the effect of this
tool on physicians’ lack of time. Physicians believed using
this tool required spending more time with patients. On
the contrary, patients thought using this tool would save
physicians’ time.
Lack of an evaluation system for monitoring patients and
physicians’ rights in decision making
Physicians thought lack of an evaluation system for
engaging patients in decision making would make
physicians act according to their own preferences. In
other countries like Canada where this tool is being used,
evaluation systems are very systematic and principled.
In one of the physicians’ opinion:
“Why doesn’t evidence-based medicine work in our
treatments? Because the physician who acts
evidence-based isn't treated differently from a
physician who does not! Acting non-academically makes
more money and creates more motivation.” (Gastro)
“Medical ethics should be important to physicians and
they should know that if they don’t adhere to them
they will be considered as serious illegal acts.” (Ophth)
Although some physicians believed that if using the tool
would become mandatory, it would assure the usage of
PDA, the majority believed mandatory plans do not work
and that physicians’ tendency to use this tool should be
raised by removing the barriers in that context.
Lack of an appropriate role model among medical
instructors
According to the participating physicians the following
barriers existed in medical education: absence of trainings
in the field of patient management, involving patients
in decision making, respecting their rights, and taking
responsibility for educating them.
“Our training process is such that when a patient visits
an attending physician, the student asks for his/her
medical history and brings him/her to me and I tell
the patient what s/he should do and that’s it! The
examination is over. ” (Endo)
They believed our medical trainings gave the students
the impression that it is the physician who must decide.Theoretical trainings are not sufficient; students should
learn these principles in practice.
“Well, actually this needs acculturation, meaning,
both its knowledge and culture should be passed on.
Only then it can be done.” (Derma)
To acculturate the physicians suggested identifying
opinion leader doctors and familiarizing them with the
principles of evidence-based and shared decision making.
This way they could promote the reception of this tool in
other medical staff as well, hence raising its applicability.
To achieve this goal, professors could play the key roles. It
was also suggested to familiarize the Ministry of Health
with the subject and highlight its significance, as it plays a
key role in implementation of new rules.
“Often there are certain people in every group and
hospital who are the key players; if those people accept
that a thing is useful then this acceptance can
influence others as well.” (Neuro).
Discussion
Our findings propose that both patients and physicians
welcome shared decision making. The main barriers in
using this tool which were mentioned by both groups of
participants were: patients’ cultural problems, awareness
issues including lack of patients’ knowledge and education,
lack of education in shared decision making for physi-
cians, both theoretically and in practice. Moreover, the
inappropriate distribution of human resources and lack
of a strong monitoring system in the health system
were other barriers mentioned by physicians in this
study. To encourage medical staff and patients toward
shared decision making, and to promote the use of
PDAs, the barriers and solutions need to be identified
at different levels of the health system.
Results from the present study and of course others
show that familiarizing patients with their rights is an
effective way of increasing their tendency toward shared
decision making. Hence focusing on raising patients’
awareness with the aim of familiarizing them with the
principles of decision making and with their own rights
is one possible solution. Since primary health services have
the most referrals from different socio-cultural classes,
it has been suggested to hold these awareness-raising
programs at different levels, including primary levels [19].
An increased likelihood of the patient’s misunderstanding
of the physician’s level of knowledge; an increased doubt
in decision making, disagreements among physicians and
patients’ choices, and lack of time were the barriers and
challenges stated by physicians, about which the patients
had completely different opinions. Physicians’ unfamiliarity
with the principles of medical ethics e.g. patients’ rights and
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these disagreements in another study [20]. Results from
different studies show that moving toward greater patient
involvement requires physicians to become more familiar
with different concepts of decision making, patients’
preferences and kinds of decisions [20-22]. It is also
recommended to pay more attention to evidence-based
medicine, with an emphasis on values and principles of
patient participation in decision making, as one of the
main elements of medical students’ educational curriculum.
Physicians’ lack of time was one of the barriers mentioned
by physicians in our study. The high numbers of referrals
made to public clinics and the inappropriate distribution of
human resources were the main reasons behind physicians’
lack of time for involving patients in decision making.
A great share of health services are being delivered by
public clinics. That is why the number of specialists
per patients referring to these centers should gain special
attention. Since most public hospitals are in charge of
training physicians, more human resources and costs
should be allocated [19,23,24].
Participating physicians thought the cost of involving
patients in decision making would not appear beneficial
to physicians, because the time they spend on exam-
ining patients is not proportionate to their incomes.
Not only can this problem marginalize patients, but it
can also lead physicians into prescribing drugs from
particular pharmaceutical companies or into advising
specific treatments that have financial benefits for them-
selves. Results from Davis et al’s study also confirm these
findings [25,26].
Although both physicians and patients recommended
using a nurse or a trained expert to compensate for
physicians’ lack of time, but according to McKeown
patients and physicians differ in their perceptions of
nurses as consultants, hence this can lead to confusion
and misunderstanding in the patient-physician relationship
[27]. Moreover, this solution can impose extra costs on the
system for educating nurses. Another solution proposed by
one of the physicians was to use educational videos. This
intervention was believed to help raise patients’ perception
of PDAs as well. Holmes’ study showed that although these
systems could work as facilitators in shared decision
making, but they decreased face to face and verbal relations
between physicians and patients and could weaken the idea
of consultation in decisions [26].
Improving skills for communicating with patients is a
pre-requisite in shared and evidence-based decision mak-
ing. This matter has been confirmed by other studies as
well [19]. Hence, in addition to the theoretical trainings
that medical students receive in the field of ethics and
clinical decision making, it is strongly advised to practic-
ally strengthen their communication skills for building
better relationships with patients as well.Identifying influential people in hospitals was another
solution underscored in this and other studies [28,29].
Influential persons are those individuals who can actually
influence clinical performance in a specific setting [30].
Therefore, by using this tool and respecting patients’
rights in practice, academic professors can be suitable
role models for students.
Creating incentives and evaluation systems for those who
use PDAs and share clinical decisions with patients is
another strategy that could be considered in this regard.
The findings of this study comply with other studies
that suggest sharing decisions with patients in accordance
with their culture, level of education, age and ethnicity
[10,31]. Physicians should be flexible, and be able to
adjust themselves to the type and amount of information
correspondent to the patients’ education and require-
ment levels [19]. Furthermore, preparing culturally-
appropriate PDAs in different fields could be another
option in universities.
Likewise, according to the participating physicians and
results of other studies, patients’ tendency toward get-
ting involved in decision making depends on the type
and severity of their disease [19,32,33].
Study limitations and strengths
The qualitative nature of the study and the purposeful
sampling done in it lowers the generalizability of the
findings. Hence, interpretation of findings should be done
with caution. As a further step, we recommend evaluating
physicians’ opinions through questionnaires designed on
the basis of the current study’s findings, with a larger
and more generalizable sample size. However, maximum
variation sampling was done for patients and physicians.
And in spite of the fact that the tool had not been used
in the country before, after conducting the interviews,
we realized that the responses given by various specialties
and patients from different socio-economic classes did
not differ significantly. Even then, we must consider that
saturation may not have been achieved from various layers
of participants and we cannot be certain of the kind of
saturation achieved. Nonetheless, to our best knowledge,
no such tool has been used in low- and middle-income
countries so far. The results of this study can therefore
give an overview and prompt the usage of patient decision
aids in developing countries such as Iran.
Conclusions
In conclusion, it seems that the PDA tool has been ac-
cepted by the majority of Iranian patients and physicians
under study. The applicability of this tool can be increased
by laying greater emphasis on patients’ rights and medical
ethics during the medical course, and informing patients of
their rights. Therefore, it seems that planning can be done
to design evidence-based PDAs that are based on patients’
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the cost-effectiveness of such tools through clinical trials
seems necessary.
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